Connecticut General Statutes
Chapter 420b - Dependency-Producing Drugs
Section 21a-278. (Formerly Sec. 19-480a). - Penalty for illegal manufacture, distribution, sale, prescription or administration by non-drug-dependent person.

(a)(1) No person may manufacture, distribute, sell, prescribe, dispense, compound, transport with the intent to sell or dispense, possess with the intent to sell or dispense, offer, give or administer to another person, except as authorized in this chapter, (A) one or more preparations, compounds, mixtures or substances containing an aggregate weight of (i) one ounce or more of heroin or methadone, or (ii) one-half ounce or more of cocaine or cocaine in a free-base form, or (B) a substance containing five milligrams or more of lysergic acid diethylamide. The provisions of this subdivision shall not apply to a person who is, at the time of the commission of the offense, a drug-dependent person.

(2) Any person who violates subdivision (1) of this subsection shall be imprisoned not less than five years or more than life. The execution of the mandatory minimum sentence imposed by the provisions of this subdivision shall not be suspended, except that the court may suspend the execution of such mandatory minimum sentence if, at the time of the commission of the offense, such person was under the age of eighteen years or such person's mental capacity was significantly impaired, but not so impaired as to constitute a defense to prosecution.
(b) (1) No person may manufacture, distribute, sell, prescribe, dispense, compound, transport with the intent to sell or dispense, possess with the intent to sell or dispense, offer, give or administer to another person, except as authorized in this chapter or chapter 420f, (A) a narcotic substance, (B) a hallucinogenic substance, (C) an amphetamine-type substance, or (D) one kilogram or more of a cannabis-type substance. The provisions of this subdivision shall not apply to a person who is, at the time of the commission of the offense, a drug-dependent person.
(2) Any person who violates subdivision (1) of this subsection (A) for a first offense, shall be imprisoned not less than five years or more than twenty years, and (B) for any subsequent offense, shall be imprisoned not less than ten years or more than twenty-five years. The execution of the mandatory minimum sentence imposed by the provisions of this subdivision shall not be suspended, except that the court may suspend the execution of such mandatory minimum sentence if, at the time of the commission of the offense, such person was under the age of eighteen years or such person's mental capacity was significantly impaired, but not so impaired as to constitute a defense to prosecution.
(1971, P.A. 812, S. 1; 1972, P.A. 278, S. 25; P.A. 73-137, S. 10; P.A. 74-332, S. 1, 6; P.A. 87-373, S. 2; P.A. 01-195, S. 92, 181; P.A. 05-248, S. 8; P.A. 06-196, S. 254; P.A. 07-217, S. 97; P.A. 17-17, S. 2.)
History: 1972 act substituted “substance” for “drug” and made provisions applicable to distributors and to hallucinogenic or amphetamine-type drugs; P.A. 73-137 substituted “such action” for “his arrest” and added proviso re life imprisonment penalty; P.A. 74-332 applied Subsec. (a) to substances containing specified amounts of heroin, methadone, cocaine or LSD, imposing minimum term of 5 to 20 years and maximum term of life imprisonment and added provisions re suspension of minimum term and added Subsec. (b) applicable to hallucinogenic, narcotic, amphetamine- or cannabis-type substances formerly dealt with in Subsec. (a), reducing minimum term for first offense from 10 to 5 years, replacing 15-year minimum and 30-year maximum for second offense and 35-year sentence for third or more offenses with 10-year minimum and 25-year maximum sentence for all offenses beyond the first and added provisions re suspension of minimum sentence; Sec. 19-480a transferred to Sec. 21a-278 in 1983; P.A. 87-373 amended Subsec. (a) to make provisions applicable to an aggregate weight of one-half gram or more of cocaine in a free-base form; P.A. 01-195 made technical changes in Subsecs. (a) and (b), effective July 11, 2001; P.A. 05-248 amended Subsec. (a) to decrease from one ounce to one-half ounce the minimum aggregate weight of cocaine and increase from one-half gram to one-half ounce the minimum aggregate weight of cocaine in a free-base form that subjects a person to the penalties of said Subsec.; P.A. 06-196 made technical changes in Subsec. (a), effective June 7, 2006; P.A. 07-217 made technical changes in Subsec. (b), effective July 12, 2007; P.A. 17-17 substantially amended Subsec. (a) re person who manufactures, distributes, sells, prescribes, dispenses, compounds, transports, possesses, offers, gives or administers preparations, compounds, mixtures or substances containing heroin or methadone with provisions re same, substantially amended Subsec. (b) re person who manufactures, distributes, sells, prescribes, dispenses, compounds, transports, possesses, offers, gives or administers narcotic, hallucinogenic, amphetamine-type or cannabis-type substance with provisions re same.
See Sec. 21a-283a re authority of court to depart from prescribed mandatory minimum sentence.
Annotations to former section 19-480a:
Cited. 166 C. 439; Id., 620. Statute on its face does not violate the constitutional prohibition against cruel and unusual punishment. 167 C. 328. Cited. 172 C. 16; 186 C. 26; 197 C. 67; 199 C. 359; 201 C. 605.
Subsec. (a):
Order directing defendant to submit to drug dependency examination is interlocutory and not appealable until conviction and final judgment. 180 C. 290. Cited. 194 C. 612; 200 C. 412.
Subsec. (b):
Cited. 179 C. 239; Id., 522. Question of burden of drug dependency is one of first impression; held that proof of drug dependency constitutes an exemption under Sec. 19-474 (21a-269) and that burden of producing some substantial evidence of drug dependency rests initially on defendant. 182 C. 142. Cited. 187 C. 469; 188 C. 183.
Annotations to present section:
Cited. 191 C. 360; 192 C. 383; 194 C. 589; 204 C. 377; 211 C. 258; 212 C. 195; 221 C. 595; 224 C. 322; 227 C. 32; 231 C. 514; Id., 941; 235 C. 477; Id., 487.
Cited. 9 CA 686; 13 CA 69; 19 CA 195; 26 CA 779; 27 CA 713; 32 CA 724; 35 CA 609; 36 CA 488; Id., 631; 41 CA 604; 42 CA 640. Defendant could not be convicted on one set of facts of both possession of narcotics by a person who is not drug-dependent and simple possession of narcotics and court ordered one sentence vacated. 60 CA 436.
Subsec. (a):
Cited. 200 C. 412. Institution of definite sentencing scheme for any felony under Sec. 53a-35a implicitly repealed indeterminate sentencing aspect of this section. 214 C. 378. Cited. 237 C. 81; 239 C. 427.
Cited. 10 CA 561; 11 CA 47; 15 CA 161; 16 CA 518; 18 CA 104; 30 CA 783; 45 CA 110. Design and effect of statute discussed; conviction for both possession and sale of narcotics does not violate prohibition against double jeopardy. 53 CA 661. Conviction of both possession of at least one-half gram of crack cocaine with intent to sell under this section and possession of powder cocaine with intent to sell under Sec. 21a-277 does not constitute double jeopardy; evidence was sufficient to support conviction of possession with intent to sell. 75 CA 223. Sentence of 35 years of incarceration does not exceed authorized sentencing limit. 127 CA 706.
Subsec. (b):
Cited. 205 C. 560; 214 C. 692; 215 C. 667; 216 C. 150, see also 223 C. 902 and 225 C. 10; 217 C. 811; 218 C. 458; 219 C. 529; Id., 752; 220 C. 6; Id., 628; 221 C. 518. Defendant bears burden of proving by preponderance of evidence that she was drug-dependent. Id., 595. Cited. Id., 925; 223 C. 283; Id., 461; Id., 703; 224 C. 253; 225 C. 650; 226 C. 514; 229 C. 60; 236 C. 176; 238 C. 380; 239 C. 629; 241 C. 322; Id., 650. Holdings in 182 C. 142 and 221 C. 595 that Subsec. creates exception for drug-dependent persons within meaning of Sec. 21a-269 and that the absence of drug dependency is not an element of the offense upheld; holding in 221 C. 595 that defendant must prove exception of drug dependency by a preponderance of the evidence upheld; requirement that defendant prove drug dependency by a preponderance of the evidence is not unconstitutional. 290 C. 24; judgment superseded, see Id., 602. Jury could reasonably conclude that defendant, who was not in exclusive possession of a vehicle containing narcotics, knew about and had control over narcotics found in the vehicle's center console from evidence that defendant closed the center console as police approached the vehicle and that a plastic bag, later determined to contain cocaine, was observed protruding from the corner of the console, and evidence that defendant was a narcotics dealer further supported the inference that defendant possessed the narcotics. 296 C. 62. Defendant's conviction of possession of a narcotic substance with intent to sell under Sec. 21a-277(a) must be vacated as a lesser included offense re his conviction of possession of a narcotic substance with intent to sell by a person who is not drug-dependent in violation of Subsec.; merger of convictions approach in 216 C. 699 overruled. 308 C. 242. The language and legislative history of P.A. 17-17 demonstrate that the legislature did not intend to effect any substantive changes to the law which makes drug dependency an affirmative defense. 329 C. 770.
Cited. 7 CA 588; 8 CA 469; 10 CA 347; 11 CA 140; 13 CA 40; 14 CA 146; Id., 807; 15 CA 519, see also 27 CA 291, 223 C. 902 and 225 C. 10; 16 CA 18; 17 CA 104; Id., 114; Id., 556; Id., 635; 18 CA 175; Id., 184; Id., 716; 19 CA 265; Id., 277; Id., 478; judgment reversed, see 216 C. 150, see also 27 CA 291, 223 C. 902 and 225 C. 10; Id., 626; Id., 640; Id., 668; 20 CA 168; judgment reversed, see 215 C. 667; Id., 183; Id., 290; Id., 386; Id., 824; 21 CA 235; Id., 474; Id., 506; Id., 519; 22 CA 1; Id., 62; judgment reversed, see 219 C. 529; Id., 303; Id., 567; Id., 665; 23 CA 358; Id., 392; Id., 426; Id., 543; Id., 559; Id., 571; Id., 592; Id., 667; Id., 746; judgment reversed, see 221 C. 595; 24 CA 158; Id., 347; Id., 642; Id., 670; Id., 678; 25 CA 3; Id., 318; Id., 575; 26 CA 86; Id., 94; Id., 259; Id., 423, see also 27 CA 291, 223 C. 902 and 225 C. 10; Id., 472; Id., 667; 27 C. 171; Id., 307; Id., 558; Id., 596; 28 CA 126; Id., 575; 29 CA 304; Id., 359; Id., 584; Id., 675; Id., 694; 30 CA 9; Id., 470; Id., 654; Id., 712; Id., 783; 31 CA 548; 32 CA 84; Id., 505; Id., 811; Id., 831; Id., 842; 33 CA 253; Id., 409; Id., 509; Id., 647; 34 CA 141; Id., 191; Id., 492; Id., 501; Id., 629; 35 CA 360; 36 CA 672; 37 CA 355; Id., 360; Id., 456; judgment reversed, see 236 C. 176; Id., 491; 38 CA 29; Id., 536; 39 CA 526; Id., 550; 41 CA 47; Id., 772; 42 CA 1; Id., 264; Id., 500; Id., 537; judgment reversed, see 241 C. 650; Id., 687; Id., 751; 43 CA 339; 45 CA 207; Id., 679. Court declines to distinguish prior case on due process challenge to unitary adjudication of sale of narcotics and drug dependency. 47 CA 86. Cited re admission of, and sufficiency of, evidence re conviction. 51 CA 824. Defendant's claim of drug dependency discussed and rejected. 62 CA 102. Trial court improperly failed to provide definition of “drug dependency” in accordance with the term's statutory definition or otherwise in its instructions to jury. 69 CA 505. Circumstantial evidence at trial provided adequate evidentiary basis for jury to find that substance at issue was LSD, which evidence included court's definition and description of LSD, defendant's statement re substance and manner of ingestion and effect of substance on person who ingested it. 85 CA 575. Defendant failed to demonstrate that his two convictions under section, resulting from searches on the same day, constituted double jeopardy because defendant was found with one stash of cocaine in his pocket, and a later search of his home found another stash of different purity, reflecting different purposes related to the cocaine; defendant did not demonstrate a due process violation regarding jury instruction on nonexclusive possession of premises where narcotics were found. 93 CA 548. Circumstantial evidence that defendant picked up package and was engaged in illicit activity was insufficient to support conviction of possession of marijuana and possession with the intent to sell marijuana when essential element of offense, knowledge of the character of the illegal substance, was lacking. 98 CA 458. Evidence sufficient to show defendant possessed requisite knowledge for conviction under statute. 110 CA 245. Defendant's conviction of possession of a narcotic substance with intent to sell in violation of Sec. 21a-277(a) must be merged with his conviction of possession of a narcotic substance with intent to sell by a person who is not drug-dependent in violation of Subsec., and his sentence for possession of narcotics with intent to sell must be vacated. 126 CA 323; judgment reversed in part re merger of convictions, see 308 C. 242. Proof that defendant knew package contained marijuana, and not a different substance, was an essential element of both the conspiracy count and accessory count; where defendant is charged as an accessory, state must prove defendant possessed 1 kilogram or more of marijuana, but need not prove that defendant knew he possessed 1 kilogram or more of marijuana. 151 CA 154.

Structure Connecticut General Statutes

Connecticut General Statutes

Title 21a - Consumer Protection

Chapter 420b - Dependency-Producing Drugs

Section 21a-240. (Formerly Sec. 19-443). - Definitions.

Section 21a-241. (Formerly Sec. 19-449). - Prior regulations continued.

Section 21a-242. (Formerly Sec. 19-450a). - Schedules of controlled substances. Exceptions.

Section 21a-243. (Formerly Sec. 19-451). - Regulations. Schedules of controlled substances.

Section 21a-244. (Formerly Sec. 19-451a). - Regulations re storage and retrieval of prescription information.

Section 21a-244a. - Drug records maintained on electronic data processing systems or media systems. Electronic identifiers. Regulations.

Section 21a-245. (Formerly Sec. 19-452). - Manufacture, sale, administering of restricted substances regulated.

Section 21a-246. (Formerly Sec. 19-453). - License to manufacture, wholesale, supply, compound, etc. Exception. License fees. License to possess and supply marijuana.

Section 21a-247. (Formerly Sec. 19-454). - Qualifications of applicant for license.

Section 21a-248. (Formerly Sec. 19-456). - Sale or dispensing of controlled drugs by licensed manufacturer or wholesaler. Records; orders. Scope of uses limited.

Section 21a-249. (Formerly Sec. 19-457). - Prescription requirements.

Section 21a-250. (Formerly Sec. 19-458). - Rights and duties of pharmacist.

Section 21a-251. (Formerly Sec. 19-459). - Dispensing of controlled substances by hospitals, infirmaries or clinics.

Section 21a-252. (Formerly Sec. 19-460). - Prescription and dispensing of controlled substances by certain practitioners. Surrender of unused substances by patients. Prescription, dispensing and administering of controlled substances to immediate fam...

Section 21a-253. - Possession of marijuana pursuant to a prescription.

Section 21a-254. (Formerly Sec. 19-461). - Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs and devices.

Section 21a-254a. - Appointment of prescription drug monitoring working group. Membership.

Section 21a-255. (Formerly Sec. 19-462). - Penalty for failure to make, furnish or keep records, statements or information. General penalty.

Section 21a-256. (Formerly Sec. 19-463). - Labeling of package or container of controlled substances.

Section 21a-257. (Formerly Sec. 19-464). - Person receiving narcotic drug to keep it in original container. Exceptions. Class D misdemeanor.

Section 21a-258. (Formerly Sec. 19-465). - Exceptions concerning possession and control.

Section 21a-259. (Formerly Sec. 19-466). - Common nuisances. Receivership of rental housing property development.

Section 21a-260. (Formerly Sec. 19-467a). - Narcotics control section in Department of Consumer Protection.

Section 21a-261. (Formerly Sec. 19-468). - Inspection of records. Entry on premises. Warrants and arrests.

Section 21a-262. (Formerly Sec. 19-469). - Commissioner's authority and duties re controlled substances. When seizing authority may destroy. Disposal by long-term care facilities, outpatient surgical facilities and home health care agencies.

Section 21a-263. (Formerly Sec. 19-469a). - Power of commissioner to receive and destroy drug paraphernalia. Records.

Section 21a-264. (Formerly Sec. 19-470). - Notice to licensing boards of violations by licensees.

Section 21a-265. (Formerly Sec. 19-471). - Inspection of prescriptions, orders, records and stocks restricted to government officers and third-party payors. Confidentiality.

Section 21a-266. (Formerly Sec. 19-472). - Prohibited acts.

Section 21a-267. (Formerly Sec. 19-472a). - Penalty for use, possession or delivery of drug paraphernalia associated with a controlled substance other than cannabis. Immunity.

Section 21a-268. (Formerly Sec. 19-473). - Misrepresentation of substance as controlled substance. Exemption.

Section 21a-269. (Formerly Sec. 19-474). - Burden of proof of exception, excuse, proviso or exemption.

Section 21a-270. (Formerly Sec. 19-474a). - Drug paraphernalia: Factors to be considered by court or other authority in determination.

Section 21a-271. (Formerly Sec. 19-474b). - Severability of provisions concerning drug paraphernalia.

Section 21a-272. (Formerly Sec. 19-475). - Preparations which may be sold and dispensed. Exceptions.

Section 21a-273. (Formerly Sec. 19-476). - Substances exempt under federal law.

Section 21a-274. (Formerly Sec. 19-477). - Cooperation in enforcement of law.

Section 21a-274a. - Drug enforcement grant program. Safe neighborhoods grant program. Community mobilization antidrug grant program.

Section 21a-275. (Formerly Sec. 19-478). - Revocation or suspension of licenses by commissioner.

Section 21a-276. (Formerly Sec. 19-479). - Discretion of commissioner to issue warning.

Section 21a-277. (Formerly Sec. 19-480). - Penalty for illegal manufacture, distribution, sale, prescription, dispensing.

Section 21a-278. (Formerly Sec. 19-480a). - Penalty for illegal manufacture, distribution, sale, prescription or administration by non-drug-dependent person.

Section 21a-278a. - Penalty for illegal manufacture, distribution, sale, prescription or administration.

Section 21a-278b. - Penalty for illegal manufacture, distribution, sale, prescription administration or growing of cannabis or cannabis products.

Section 21a-278c. - (Note: This section is effective July 1, 2023.) Cultivation of cannabis plants in consumer's primary residence.

Section 21a-279. (Formerly Sec. 19-481). - Penalty for illegal possession of a controlled substance other than cannabis. Alternative sentences. Immunity.

Section 21a-279a. - Limits for legal possession of cannabis. Penalty for illegal possession. Calculation of amount and equivalencies.

Section 21a-279b. - Construction of public act 15-2 of the June special session* re violations of section 21a-279.

Section 21a-279c. - Exceptions for seeking medical assistance for medical distress from use of cannabis.

Section 21a-279d. - Cannabis given by one consumer to another.

Section 21a-280. (Formerly Sec. 19-481a). - Breathing of anesthesia not violation.

Section 21a-281. (Formerly Sec. 19-481b). - Presumption of psychological dependence on volatile substances.

Section 21a-282. (Formerly Sec. 19-482). - No prosecution where federal action has been taken.

Section 21a-283. (Formerly Sec. 19-483). - Analytical tests for presence of controlled drugs or alcohol. Standards and procedures. Convictions constituting prior offense. Imposition of cost when analysis performed.

Section 21a-283a. - Court authorized to depart from imposing mandatory minimum sentence.

Section 21a-284 and 21a-285. (Formerly Secs. 19-484 and 19-485). - Suspension of prosecution for treatment for drug dependence; dismissal of charges. Order for treatment in addition to penalties on conviction; penalty for unauthorized departure from...

Section 21a-286. - Agreements for distribution and administration of opioid antagonists. Regulations.

Section 21a-254. (Formerly Sec. 19-461). *(See end of section for - Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs an...

Section 21a-301 to 21a-305. (Formerly Secs. 19-504a, 19-504c to 19-504e, - Definitions. Regulations. Inspections of: Institutional pharmacies, pharmacist's drug rooms and dispensing outpatient facilities; correctional and juvenile training institutio...

Section 21a-307. (Formerly Sec. 19-504i). - Definitions re dispensing of drugs.